Discovery, Synthesis and Activity Evaluation of Novel Compounds Bearing 1,2,4-triazolo[3,4-b][1,3,4]thiadiazine Moiety: A Review
Abstract
Lately, much interest has been focused on the chemistry and the biological activity of fused heterocyclic compounds carrying nitrogen atoms because of their utility in various applications, and over the years N-bridged heterocyclic systems derived from 1,2,4-triazoles attracted the interest of researchers owing to the hopeful promise of their pharmacological activities such as antimicrobial, antifungal, molluscicidal, nematicidal, analgesic, anti-inflammatory, anticancer, phosphodiesterase 4 inhibitor, acetylcholinesterase, butyrylcholinesterases and alkaline phosphatase inhibitor. The fused ring of triazole and thiadiazines, named as triazolothiadiazines, represents a specific and important class of N-bridged heterocycles with their remarkable and wide range of biological activity and there are not enough studies that include the current developments associated with the new synthesis techniques and novel biological evaluation results of 1,2,4-triazolo[3,4-b][1,3,4] thiadiazine derivatives. In an attempt to overcome this deficiency in the literature, we deeply researched the literature and formed a review study about the discovery, synthesis and activity evaluation of new compounds bearing 1,2,4-triazolo[3,4-b][1,3,4]thiadiazine moiety within the years of 1996-2019. We aimed to provide scientists with a wide data resource about 1,2,4-triazolo[3,4-b][1,3,4]thiadiazine derivatives, thus helping them perform a more organized and fertile drug discovery operation during their experimental studies.
Keywords
References
- 1. Abdel-Wahab, B.F., Abdel-Aziz, H.A., Ahmed, E.M. (2009): Synthesis and antimicrobial evaluation of some 1,3-thiazole, 1,3,4-thiadiazole, 1,2,4-triazole, and 1,2,4-triazolo[3,4-b][1,3,4]-thiadiazine derivatives including a 5-(benzofuran-2-yl)-1-phenylpyrazole moiety, Monatshefte für Chemie-Chemical Monthly, 140(6): 601-605.
- 2. Ahmad, A., Varshney, H., Rauf, A., Sherwani, A., Owais, M. (2017): Synthesis and anticancer activity of long chain substituted 1,3,4-oxadiazol-2-thione, 1,2,4-triazol-3-thione and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazine derivatives, Arabian Journal of Chemistry, 10: 3347-3357.
- 3. Aytac, S.P., Tozkoparan, B., Kaynak, F.B., Aktay, G., Göktaş, Ö., Ünüvar, S. (2009): Synthesis of 3,6-disubstituted 7H-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines as novel analgesic/anti-inflammatory compounds, European Journal of Medicinal Chemistry, 44(11): 45284538.
- 4. Badr, S.M., Barwa, R.M. (2011): Synthesis of some new [1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles starting from 5-nitro-2-furoic acid and evaluation of their antimicrobial activity, Bioorganic & Medicinal Chemistry, 19(15): 4506-4512.
- 5. Baeeri, M., Foroumadi, A., Motamedi, M., YahyaMeymandi, A., Firoozpour, L., Ostad, S.N., Shafiee, A., Souzangarzadeh, S., Abdollahi, M. (2011): Safety and Efficacy of New 3,6‐diaryl‐7H‐[1,2,4]triazolo[3,4‐b] [1,3,4]thiadiazine Analogs as Potential Phosphodiesterase‐4 Inhibitors in NIH‐3T3 Mouse Fibroblastic Cells, Chemical Biology & Drug Design, 78(3): 438444.
- 6. El Shehry, M.F., Abu-Hashem, A.A., El-Telbani, E.M. (2010): Synthesis of 3-((2,4-dichlorophenoxy)methyl)-1,2,4-triazolo(thiadiazoles and thiadiazines) as anti-inflammatory and molluscicidal agents, European Journal of Medicinal Chemistry, 45(5): 19061911.
- 7. Ergenc, N., Ulusoy, N., Çapan, G., Sanis, G.Ö., Kiraz, M. (1996): Synthesis and Antimicrobial Properties of New 4‐(Alkylidene/arylidene)‐amino‐5‐(2‐furanyl)‐2, 4‐dihydro‐3H‐1,2,4‐triazole‐3‐thiones and 6‐Aryl‐3‐(2‐furanyl)‐7H‐1,2,4‐triazolo[3,4‐b][1,3,4] thiadiazines, Archiv der Pharmazie, 329(8‐9): 427430.
- 8. Holla, B.S., Rao, B.S., Sarojini, B.K., Akberali, P.M., Kumari, N.S. (2006): Synthesis and studies on some new fluorine containing triazolothiadiazines as possible antibacterial, antifungal and anticancer agents, European Journal of Medicinal Chemistry, 41(5): 657-663.
Details
Primary Language
English
Subjects
Pharmacology and Pharmaceutical Sciences
Journal Section
Conference Paper
Authors
Efe Doğukan Dincel
*
This is me
0000-0002-5445-0600
Türkiye
Nuray Ulusoy Güzeldemirci
This is me
0000-0002-4495-4282
Türkiye
Publication Date
September 6, 2019
Submission Date
January 23, 2019
Acceptance Date
June 10, 2019
Published in Issue
Year 2019 Volume: 2 Number: 2